Pune, India

Sanjay Kisan Dabhade

This inventor holds 6 USPTO granted patents and 2 EPO patents. Top assignee: Wockhardt Limited. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanjay Kisan Dabhade. Retrieved from https://idiyas.com/inventor/sanjay-kisan-dabhade

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 14(Granted Patents)


Location History:

  • Pune, IN (2015 - 2017)
  • Maharashtra, IN (2017)

Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Sanjay Kisan Dabhade

Introduction

Sanjay Kisan Dabhade is a notable inventor based in Pune, India. He has made significant contributions to the field of antibacterial agents, holding a total of six patents. His work focuses on developing compounds that can effectively prevent or treat bacterial infections.

Latest Patents

Dabhade's latest patents include innovative compounds such as 2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]octane derivatives. These compounds are disclosed for their preparation and use as antibacterial agents. Another significant patent involves nitrogen-containing compounds, which also serve as antibacterial agents, highlighting their potential in medical applications.

Career Highlights

Sanjay Kisan Dabhade is currently associated with Wockhardt Limited, a prominent pharmaceutical company. His work at Wockhardt has allowed him to focus on research and development in the field of antibacterial treatments, contributing to advancements in healthcare.

Collaborations

Dabhade has collaborated with notable colleagues such as Sachin Subhash Bhagwat and Prasad Keshav Deshpande. These collaborations have fostered a productive environment for innovation and research in their respective fields.

Conclusion

Sanjay Kisan Dabhade's contributions to antibacterial research through his patents and collaborations underscore his importance in the field of pharmaceuticals. His work continues to pave the way for new treatments that can combat bacterial infections effectively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…